Abstract Objectives The European Society for Clinical and Economic Aspects of
Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) sought to revisit the …

In times of health crisis, including the current COVID‐19 pandemic, the potential benefit of
botanical drugs and supplements emerges as a focus of attention, although controversial …

Background The aim of this clinical trial was to assess the efficacy and safety of curcuminoid
complex extract from turmeric rhizome with turmeric volatile oil (CuraMed®) and its …

Background Osteoarthritis (OA) is the commonest form of inflammatory joint disease.
Unfortunately, to date, there is no appropriate treatment for OA. Boswellia serrata was …

Chronic joint inflammatory disorders such as osteoarthritis and rheumatoid arthritis have in
common an upsurge of inflammation, and oxidative stress, resulting in progressive …

Background Symptomatic slow-acting drugs for osteoarthritis (SYSADOAs) are an important
drug class in the treatment armamentarium for osteoarthritis (OA). Objective We aimed to re …

Background A EULAR taskforce was convened to develop recommendations for lifestyle
behaviours in rheumatic and musculoskeletal diseases (RMDs). In this paper, the literature …

Objective To assess the efficacy and safety of topical Matricaria chamomilla (Chamomile) oil
in patients with knee osteoarthritis. Method Patients were randomized and treated with …

Osteoarthritis (OA) is a chronic disability that significantly impairs quality of life. OA is one of
the most prevalent joint pathologies in the world, characterized by joint pain and stiffness …

Purpose The unfavorable safety profiles of commonly prescribed knee osteoarthritis (OA)
treatments have led clinicians and patients to seek safer alternatives. Research has …